Episode summary

WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak

Schwab Network · · Hosts: Kevin Green

WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak – Schwab Network

Summary

Wall Street is selling the news on strong earnings, with the analyst saying investors are focusing less on fundamentals and more on AI capex fears, credit stress, and a weaker tech tape. He said technology and communication services were under pressure, and that the market is watching whether the Nasdaq 100 can hold a key moving average or roll over into broader weakness. He also said more stocks tied to memory and semis are already in bear market territory, which he thinks is a warning sign for the S&P 500’s forward momentum.

Western Digital beat estimates and raised guidance, with revenue up 55% year over year to $4.4 billion and gross margin at 58.1%, but the stock still fell because expectations were so high. Bloom Energy also beat on revenue at $1.24 billion, yet shares slipped after missing in parts of its core business and facing a lofty valuation. In both cases, the analyst argued the market wants more than just good results.

Moderna dropped after cancer vaccine data leaked ahead of a weekend oncology meeting. The analyst said the trial results were generally solid, but not exciting enough for investors hoping for a bigger breakthrough. Crude oil moving toward $100 and geopolitical risk in the Middle East are adding another layer of volatility to equities.

Key takeaways

  • The analyst said strong earnings are not enough right now because traders are selling the news and rotating away from technology and communication services.
  • Western Digital beat estimates, raised its dividend 17%, and lifted guidance, but the stock still sold off because the bar was already very high.
  • Bloom Energy beat revenue estimates, yet the analyst said its utility-like business faces a lofty multiple and investors wanted more from core segments.
  • Moderna fell after leaked cancer vaccine data showed a 42% cut in recurrence or death risk, which the analyst said was good but not the breakthrough some investors wanted.
  • The analyst said crude’s rise toward $100 and Middle East tensions are pushing up volatility and could drive a wide trading range in the S&P 500.

Notable quotes

“It seems like these earnings announcements even though they are good, when you're looking at the fundamentals, you are seeing some traders and investors kind of selling the news on this”

— A speaker on Schwab Network at 0:35

“we are seeing a correction an bear market territory for a lot of these stocks related to memory as well as nes”

— A speaker on Schwab Network at 2:02

“good. Seems to be not good enough when it comes to the tech trade particular”

— A speaker on Schwab Network at 2:21

“It just seems like it's taking a little bit longer to kind of get these projects online”

— A speaker on Schwab Network at 4:46

“The risk of recu of death was actually cut by 42%. Street was looking for 40%”

— A speaker on Schwab Network at 8:14

Topics

  • ai capex
  • crude oil prices
  • bear market territory
  • earnings declines
  • cancer vaccine trial news

Companies and tickers mentioned

  • WDC
  • BE
  • MRNA
  • Western Digital
  • Bloom Energy
  • Moderna

Watch the episode

Watch “WDC & BE Slide After Earnings as Crude Crosses $100; MRNA Cancer Vaccine Data Leak” on YouTube

Summary, takeaways and quote selection by Octagon. Quotes are short excerpts; the full conversation is in the episode.

More from Schwab Network

All Schwab Network episodes →

Schwab Network, this episode and its artwork belong to their owners. Octagon is not affiliated with the show; this page is an independent summary.